Howard Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
1,064
-622
-37% -$134K 0.1% 128
2026
Q1
$367K Sell
1,686
-44
-3% -$9.76K 0.15% 98
2025
Q4
$396K Sell
1,730
-46
-3% -$10.5K 0.17% 90
2025
Q3
$411K Buy
1,776
+2
+0.1% +$407 0.19% 86
2025
Q2
$329K Sell
1,774
-19
-1% -$3.53K 0.17% 92
2025
Q1
$376K Sell
1,793
-6
-0.3% -$1.17K 0.21% 85
2024
Q4
$320K Sell
1,799
-71
-4% -$13.1K 0.17% 88
2024
Q3
$369K Buy
1,870
+9
+0.5% +$1.68K 0.22% 84
2024
Q2
$319K Hold
1,861
0.25% 72
2024
Q1
$339K Buy
1,861
+56
+3% +$9.65K 0.28% 69
2023
Q4
$280K Hold
1,805
0.23% 81
2023
Q3
$269K Hold
1,805
0.25% 77
2023
Q2
$243K Sell
1,805
-361
-17% -$52.9K 0.21% 86
2023
Q1
$345K Sell
2,166
-82
-4% -$12.5K 0.29% 72
2022
Q4
$363K Sell
2,248
-51
-2% -$7.82K 0.3% 72
2022
Q3
$308K Buy
+2,299
New +$330K 0.22% 89
2022
Q2
Sell
-2,205
Closed -$357K 63
2022
Q1
$357K Buy
2,205
+29
+1% +$4.21K 0.19% 92
2021
Q4
$294K Buy
2,176
+190
+10% +$22.4K 0.16% 105
2021
Q3
$214K Buy
1,986
+4
+0.2% +$457 0.12% 120
2021
Q2
$223K Sell
1,982
-25
-1% -$2.82K 0.12% 120
2021
Q1
$217K Sell
2,007
-90
-4% -$9.63K 0.13% 119
2020
Q4
$224K Buy
+2,097
New +$202K 0.14% 114
2020
Q1
Sell
-1,837
Closed -$162K 99
2019
Q4
$162K Buy
+1,837
New +$153K 0.14% 109

Other funds holding ABBV

Howard Wealth Management's ABBV Position: Q2 2026 in Review

Howard Wealth Management reduced its AbbVie (ABBV) stake by 37% in Q2 2026, selling an estimated $134K and leaving 1,064 shares worth $268K. The position accounts for 0.1% of the portfolio, ranked #128.

Howard Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 23 quarters since. The position peaked at $411K in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Howard Wealth Management held 1,064 shares of AbbVie worth $268K as of Q2 2026.
  • Howard Wealth Management sold 622 AbbVie shares in Q2 2026, an estimated $134K.
  • AbbVie made up 0.1% of Howard Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Howard Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 23 quarters since.
  • Howard Wealth Management's AbbVie position peaked at $411K in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Howard Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.